131 related articles for article (PubMed ID: 32168264)
1. Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer.
Hodolic M; Ambrosini V; Fanti S
Nucl Med Commun; 2020 May; 41(5):411-415. PubMed ID: 32168264
[TBL] [Abstract][Full Text] [Related]
2. Radiopharmaceuticals for imaging and endoradiotherapy of neurotensin receptor-positive tumors.
Maschauer S; Prante O
J Labelled Comp Radiopharm; 2018 Mar; 61(3):309-325. PubMed ID: 29114915
[TBL] [Abstract][Full Text] [Related]
3. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of neurotensin receptor 1 as a potential imaging target in pancreatic ductal adenocarcinoma.
Yin X; Wang M; Wang H; Deng H; He T; Tan Y; Zhu Z; Wu Z; Hu S; Li Z
Amino Acids; 2017 Aug; 49(8):1325-1335. PubMed ID: 28536844
[TBL] [Abstract][Full Text] [Related]
5. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.
Wu Z; Li L; Liu S; Yakushijin F; Yakushijin K; Horne D; Conti PS; Li Z; Kandeel F; Shively JE
J Nucl Med; 2014 Jul; 55(7):1178-84. PubMed ID: 24854793
[TBL] [Abstract][Full Text] [Related]
6. Development of [
Wang M; Zhang H; Wang H; Feng H; Deng H; Wu Z; Lu H; Li Z
Mol Pharm; 2018 Aug; 15(8):3093-3100. PubMed ID: 29889537
[TBL] [Abstract][Full Text] [Related]
7. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
Alshoukr F; Rosant C; Maes V; Abdelhak J; Raguin O; Burg S; Sarda L; Barbet J; Tourwé D; Pelaprat D; Gruaz-Guyon A
Bioconjug Chem; 2009 Aug; 20(8):1602-10. PubMed ID: 19610615
[TBL] [Abstract][Full Text] [Related]
8. Evidence of
Marenco M; Lodola L; Persico MG; Frangipane V; Facoetti A; Aprile C; Hodolič M
Curr Pharm Biotechnol; 2018; 19(9):754-759. PubMed ID: 30160211
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1.
Wang JG; Li NN; Li HN; Cui L; Wang P
Neuropeptides; 2011 Apr; 45(2):151-6. PubMed ID: 21272935
[TBL] [Abstract][Full Text] [Related]
10. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.
Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A
Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin analogs by fluoroglycosylation at N
Schindler L; Wohlfahrt K; Gluhacevic von Krüchten L; Prante O; Keller M; Maschauer S
Sci Rep; 2022 Sep; 12(1):15028. PubMed ID: 36056076
[TBL] [Abstract][Full Text] [Related]
12. (18)F- and (68)Ga-Labeled Neurotensin Peptides for PET Imaging of Neurotensin Receptor 1.
Maschauer S; Einsiedel J; Hübner H; Gmeiner P; Prante O
J Med Chem; 2016 Jul; 59(13):6480-92. PubMed ID: 27336295
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation of
Prignon A; Provost C; Alshoukr F; Wendum D; Couvelard A; Barbet J; Forgez P; Talbot JN; Gruaz-Guyon A
Mol Pharm; 2019 Jun; 16(6):2776-2784. PubMed ID: 31013092
[TBL] [Abstract][Full Text] [Related]
14. Imaging Neurotensin Receptor in Prostate Cancer With
Deng H; Wang H; Zhang H; Wang M; Giglio B; Ma X; Jiang G; Yuan H; Wu Z; Li Z
Mol Imaging; 2017; 16():1536012117711369. PubMed ID: 28849698
[TBL] [Abstract][Full Text] [Related]
15. Improved radiosynthesis and preliminary in vivo evaluation of a (18)F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2.
Maschauer S; Greff C; Einsiedel J; Ott J; Tripal P; Hübner H; Gmeiner P; Prante O
Bioorg Med Chem; 2015 Jul; 23(14):4026-33. PubMed ID: 25691211
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.
Reubi JC; Waser B; Friess H; Büchler M; Laissue J
Gut; 1998 Apr; 42(4):546-50. PubMed ID: 9616318
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of SR 48692 sensitive neurotensin receptor in human pancreatic cancer cells, MIA PaCa-2.
Yamada M; Ohata H; Momose K; Yamada M; Richelson E
Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):37-47. PubMed ID: 8581347
[TBL] [Abstract][Full Text] [Related]
18. Design of Bimodal Ligands of Neurotensin Receptor 1 for Positron Emission Tomography Imaging and Fluorescence-Guided Surgery of Pancreatic Cancer.
Renard E; Dancer PA; Portal C; Denat F; Prignon A; Goncalves V
J Med Chem; 2020 Mar; 63(5):2426-2433. PubMed ID: 31855417
[TBL] [Abstract][Full Text] [Related]
19. Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTc.
Nock BA; Nikolopoulou A; Reubi JC; Maes V; Conrath P; Tourwé D; Maina T
J Med Chem; 2006 Jul; 49(15):4767-76. PubMed ID: 16854083
[TBL] [Abstract][Full Text] [Related]
20. Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS
Fanelli R; Chastel A; Previti S; Hindié E; Vimont D; Zanotti-Fregonara P; Fernandez P; Garrigue P; Lamare F; Schollhammer R; Balasse L; Guillet B; Rémond E; Morgat C; Cavelier F
Bioconjug Chem; 2020 Oct; 31(10):2339-2349. PubMed ID: 32887526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
